Shigeki Sugiura
Overview
Explore the profile of Shigeki Sugiura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oguchi M, Li Y, Matsumoto Y, Kiyonari T, Yamamoto K, Sugiura S, et al.
Sci Rep
. 2023 Jan;
13(1):1419.
PMID: 36697448
Humans form complex societies in which we routinely engage in social decision-making regarding the allocation of resources among ourselves and others. One dimension that characterizes social decision-making in particular is...
2.
Nishimura K, Ikehata H, Douki T, Cadet J, Sugiura S, Mori T
Photochem Photobiol
. 2020 Dec;
97(3):582-588.
PMID: 33274440
The UVA and UVB components of sunlight can produce three classes of bipyrimidine DNA photolesions [cyclobutane pyrimidine dimers (CPDs), pyrimidine (6-4) pyrimidone photoproducts (6-4PPs) and related Dewar valence isomers (DewarPPs)]....
3.
Nukuzuma S, Nukuzuma C, Kameoka M, Sugiura S, Nakamichi K, Tasaki T, et al.
Jpn J Infect Dis
. 2020 Aug;
74(1):48-53.
PMID: 32741932
JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a demyelinating disease of the central nervous system affecting immunocompromised patients. The study of PML-type JCPyV in vitro has been limited owing...
4.
Mori T, Nakane H, Iwamoto T, Krokidis M, Chatgilialoglu C, Tanaka K, et al.
DNA Repair (Amst)
. 2019 Jul;
80:52-58.
PMID: 31279170
Xeroderma pigmentosum (XP) is a genetic disorder associated with defects in nucleotide excision repair, a pathway that eliminates a wide variety of helix-distorting DNA lesions, including ultraviolet-induced pyrimidine dimers. In...
5.
Nukuzuma S, Nukuzuma C, Kameoka M, Sugiura S, Nakamichi K, Tasaki T, et al.
Microbiol Immunol
. 2018 Jun;
62(8):524-530.
PMID: 29932215
JC polyomavirus (JCPyV) is the causative agent of progressive multifocal leukoencephalopathy (PML), a demyelinating disease of the central nervous system in immunocompromised patients. Archetype JCPyV circulates in the human population....
6.
Nukuzuma S, Nukuzuma C, Kameoka M, Sugiura S, Nakamichi K, Tasaki T, et al.
Microbiol Immunol
. 2017 May;
61(6):232-238.
PMID: 28463406
JC polyomavirus (JCPyV) is the causative agent of the demyelinating disease of the central nervous system known as progressive multifocal leukoencephalopathy (PML), which occurs in immunocompromised patients. Moreover, patients treated...
7.
Nukuzuma S, Nakamichi K, Kameoka M, Sugiura S, Nukuzuma C, Tasaki T, et al.
Microbiol Immunol
. 2016 Mar;
60(4):253-60.
PMID: 26935240
JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system, in immunocompromised patients. Because no drugs have been approved for treating PML, many...
8.
Nukuzuma S, Sugiura S, Nakamichi K, Kameoka M, Nukuzuma C, Tasaki T, et al.
Microbiol Immunol
. 2015 Feb;
59(4):238-42.
PMID: 25659831
It has been difficult to study JCV replication because of its restricted host range. In this study, JCV replication was examined using different clones in 293 cells. RT-PCR assay revealed...
9.
Iwamoto T, Brooks P, Nishiwaki T, Nishimura K, Kobayashi N, Sugiura S, et al.
Photochem Photobiol
. 2014 Jan;
90(4):829-36.
PMID: 24471831
Xeroderma pigmentosum (XP) is a genetic disorder associated with defects in nucleotide excision repair, which eliminates a wide variety of helix-distorting types of DNA damage including sunlight-induced pyrimidine dimers. In...
10.
Nukuzuma S, Nakamichi K, Kameoka M, Sugiura S, Nukuzuma C, Tasaki T, et al.
J Med Virol
. 2014 Jan;
86(12):2026-32.
PMID: 24415534
JC polyomavirus (JCV) causes progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system (CNS) in immunocompromised patients, and particularly in the severe immunosuppression associated with acquired...